Karri A. Meleo

508 citations
7 papers · 277 indexed · h-index 6

Karri A. Meleo

7 papers receiving 269 citations

Peers

Karri A. Meleo
Comparison fields: 5 of 48
  • Pulmonary and Respiratory Medicine 193
  • Immunology 118
  • Small Animals 100
  • Genetics 73
  • Molecular Biology 53
Replace M. Lagadic with:
M. Lagadic France
Pamela D. Jones United States
Cecilia Robat United States
Sara D. Allstadt United States
J. P. de Vos Netherlands
Carrie A. Wood United States
Lisa A. Mestrinho Portugal
K. W. Head United Kingdom
D. Meier Switzerland
M.A. Sánchez Spain
Karri A. Meleo relative to M. Lagadic France M. Lagadic's profile →
Citations per field
00.5×
M. Lagadic · 1×
Citations per year

Countries citing papers authored by Karri A. Meleo

Since Specialization
Citations

This map shows the geographic impact of Karri A. Meleo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karri A. Meleo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karri A. Meleo more than expected).

Fields of papers citing papers by Karri A. Meleo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karri A. Meleo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karri A. Meleo. The network helps show where Karri A. Meleo may publish in the future.

Co-authorship network of co-authors of Karri A. Meleo

This figure shows the co-authorship network connecting the top 25 collaborators of Karri A. Meleo. A scholar is included among the top collaborators of Karri A. Meleo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karri A. Meleo. Karri A. Meleo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 8
2
Biological activity of toceranib (Palladia) in canine anal gland anal SAC adenocarcinoma (AGASACA)
1
3 160
4 23
5 59
6 17
7
Management of insuloma patients with refractory hypoglycemia.
9

About Karri A. Meleo

Karri A. Meleo is a scholar working on Small Animals, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 7 papers that have together received 277 indexed citations. Recurring topics across this work include Veterinary Oncology Research (4 papers), Virus-based gene therapy research (2 papers) and Infectious Diseases and Mycology (2 papers). The work is most often cited by research in Small Animals (100 citations), Pulmonary and Respiratory Medicine (193 citations) and Immunology (118 citations). Karri A. Meleo has collaborated with scholars based in United States. Frequent co-authors include Amiya K. Patnaik, G. Neal Mauldin, Mary K. Klein, Philip J. Bergman, Maribeth H. Johnson, Nicole F. Leibman, Jedd D. Wolchok, Ilene D. Kurzman, Paul R. Hess and Pamela D. Jones. Their work appears in journals such as Journal of Veterinary Internal Medicine, American Journal of Veterinary Research and Veterinary and Comparative Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026